Encephalomyelitis [clinicaltrials_resource:2d0c6b51d2127fabdf3f3f6cbf22c181]
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone [clinicaltrials:NCT00004645]The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome [clinicaltrials:NCT00215800]clinicaltrials:NCT00344253Biobank For MS And Other Demyelinating Diseases [clinicaltrials:NCT00445367]clinicaltrials:NCT00582088Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine [clinicaltrials:NCT00582504]Survey and Cognitive Behavior Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis [clinicaltrials:NCT00920777]Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue [clinicaltrials:NCT00983502]clinicaltrials:NCT01040429B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome [clinicaltrials:NCT01156909]clinicaltrials:NCT01156922clinicaltrials:NCT01730495clinicaltrials:NCT01966276clinicaltrials:NCT02444091
condition browse [clinicaltrials_vocabulary:condition-browse]
Phase III Randomized, Double-Blind, Sham-Controlled Study of Plasma Exchange for Acute Severe Attacks of Inflammatory Demyelinating Disease Refractory to Intravenous Methylprednisolone [clinicaltrials:NCT00004645]The Study of the Safety and Efficacy of Ampligen in Chronic Fatigue Syndrome [clinicaltrials:NCT00215800]clinicaltrials:NCT00344253Biobank For MS And Other Demyelinating Diseases [clinicaltrials:NCT00445367]clinicaltrials:NCT00582088Safety and Immunogenicity Study of the Venezuelan Equine Encephalomyelitis Vaccine [clinicaltrials:NCT00582504]Survey and Cognitive Behavior Therapy for Chronic Fatigue Syndrome/Myalgic Encephalomyelitis [clinicaltrials:NCT00920777]Pilot Study of Alternative Treatments of Unexplained Chronic Fatigue [clinicaltrials:NCT00983502]clinicaltrials:NCT01040429B-cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Chronic Fatigue Syndrome [clinicaltrials:NCT01156909]clinicaltrials:NCT01156922clinicaltrials:NCT01730495clinicaltrials:NCT01966276clinicaltrials:NCT02444091
condition mesh [clinicaltrials_vocabulary:condition-mesh]
Encephalomyelitis [clinicaltrials_resource:2d0c6b51d2127fabdf3f3f6cbf22c181]
Bio2RDF identifier
2d0c6b51d2127fabdf3f3f6cbf22c181
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:2d0c6b51d2127fabdf3f3f6cbf22c181
identifier
clinicaltrials_resource:2d0c6b51d2127fabdf3f3f6cbf22c181
title
Encephalomyelitis
@en
type
label
Encephalomyelitis [clinicaltrials_resource:2d0c6b51d2127fabdf3f3f6cbf22c181]
@en
Encephalomyelitis